Parkinson Disease  >>  carbidopa/levodopa  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
carbidopa/levodopa / Generic mfg.
NCT00129181 / 2004-001485-41: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Completed
N/A
30
Europe
cabergoline, carbidopa/levodopa, DATscan and SPECT imaging
Institute for Neurodegenerative Disorders, Pfizer, GE Healthcare
Parkinson Disease, Parkinsonian Syndrome
12/06
01/07
NCT00460954: A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

Completed
N/A
20
Canada
Sinemet® controlled release (Carbidopa/levodopa)
Bristol-Myers Squibb
Parkinson's Disease
 
08/07
NCT00624741: Compassionate Use Study of Pergolide in Patients With Parkinson's Disease

No Longer Available
N/A
US
Pergolide, Permax
Bausch Health Americas, Inc.
Parkinson Disease
 
 
NCT01528592: PharmacoMRI of Parkinson Disease

Completed
N/A
18
US
Carbidopa-Levodopa
Northwestern University
Parkinson's Disease
07/12
07/12
NCT01754129: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

Completed
N/A
148
NA
AbbVie (prior sponsor, Abbott)
Parkinson's Disease
05/16
05/16

Download Options